{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T02:04:54Z","timestamp":1772762694105,"version":"3.50.1"},"reference-count":43,"publisher":"BMJ","issue":"6655","license":[{"start":{"date-parts":[[1988,10,22]],"date-time":"1988-10-22T00:00:00Z","timestamp":593481600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.bmj.com\/company\/legal-information\/terms-conditions\/legal-information\/tdm-licencepolicy"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMJ"],"published-print":{"date-parts":[[1988,10,22]]},"abstract":"<jats:p>OBJECTIVE: To evaluate the prophylactic effect of ranitidine 150 mg twice daily in patients requiring one of the following non-steroidal anti-inflammatory drugs: naproxen, piroxicam, diclofenac, and indomethacin. In addition, risk factors were studied in order to help in targeting of such treatment to specific groups of patients. DESIGN: Double blind, placebo controlled, randomised, parallel group with endoscopic assessments at 0, 4, and 8 weeks. SETTING: Multicentre outpatient study at secondary referral centres in five European countries. PATIENTS--297 patients with rheumatoid arthritis or osteoarthritis over the age of 18 without lesions in the stomach and duodenum at baseline endoscopy (after one week without taking non-steroidal anti-inflammatory drugs). Those taking other antirheumatic agents, concomitant ulcerogenic drugs, or treatment for peptic ulcers within the previous 30 days were excluded. Age, sex, arthritic disease, and type of non-steroidal anti-inflammatory drug used were comparable in the two treatment groups. In all, 263 patients completed the trial. INTERVENTIONS: Ranitidine 150 mg twice daily or placebo (plus the selected non-steroidal anti-inflammatory drug) was prescribed within five days after the baseline endoscopy for two consecutive periods of four weeks. Paracetamol was permitted during the study, but not antacids. Patients were withdrawn if the most severe grade of damage (including ulceration) was found at the four week endoscopy or when indicated, or with lesser damage at the investigator's discretion. END POINT: Frequency of gastric and duodenal ulceration or lesions, or both. MEASUREMENTS AND MAIN RESULTS: The cumulative incidence of peptic ulceration by eight weeks was 10.3% (27\/263); 2 out of 135 (1.5%) developed duodenal ulceration in the ranitidine group, compared with 10 out of 126 (8%) taking placebo. The frequency of gastric ulceration was the same (6%) for the two groups at eight weeks. Though significantly fewer gastric lesions developed in the ranitidine group by eight weeks. The frequency of non-ulcerative lesions in the duodenum did not differ greatly for the two groups at either time point. Twelve out of 75 (16%) patients taking piroxicam developed peptic ulceration, of whom two thirds had duodenal ulceration. Patients with a history of peptic ulcer were particularly susceptible to recurrent ulceration, against which ranitidine offered some protection. CONCLUSIONS: Ranitidine 150 mg twice daily significantly reduced the incidence of duodenal ulceration but not gastric ulceration when prescribed concomitantly with one of four commonly used non-steroidal anti-inflammatory drugs.<\/jats:p>","DOI":"10.1136\/bmj.297.6655.1017","type":"journal-article","created":{"date-parts":[[2009,4,2]],"date-time":"2009-04-02T15:19:55Z","timestamp":1238685595000},"page":"1017-1021","source":"Crossref","is-referenced-by-count":279,"title":["Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine."],"prefix":"10.1136","volume":"297","author":[{"given":"R. S.","family":"Ehsanullah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. C.","family":"Page","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Tildesley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. R.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[1988,10,22]]},"reference":[{"key":"ref_1","first-page":"147","article-title":"Ulcerogenicity of piroxicam: an analysis of spontaneously reported data","volume":"129","author":"Rossi, C.A.; Hus, J.P.; Faich, G.A.","year":"1987","unstructured":"Rossi CA, Hus JP, Faich GA. Ulcerogenicity of piroxicam: an analysis of spontaneously reported data. BrMedJ 1987;129:147-50.","journal-title":"BrMedJ"},{"issue":"5","key":"ref_2","first-page":"3","article-title":"A review of upper gastrointestinal effects of the newer non-steroidal anti-inflammatory agents","volume":"24","author":"Pemberton, R.E.; Strand, L.J.","year":"1979","unstructured":"Pemberton RE, Strand LJ. A review of upper gastrointestinal effects of the newer non-steroidal anti-inflammatory agents. Dig Dis Sci 1979;24:5 3-64.","journal-title":"Dig Dis Sci"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/0002-9343(83)90326-1","article-title":"Pharmacology of non-steroidal anti-inflammatory drugspractical review for clinicians","volume":"75","author":"O'Brien, W.M.","year":"1983","unstructured":"O'Brien WM. Pharmacology of non-steroidal anti-inflammatory drugspractical review for clinicians. AmJ Med 1983;75:32-9.","journal-title":"AmJ Med"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/0002-9343(83)91073-2","article-title":"From experiment to experience: side effects of non-steroidal anti-inflammatory drugs","volume":"74","author":"Coles, L.S.; Fries, J.F.; Kraines, R.G.; Roth, S.H.","year":"1983","unstructured":"Coles LS, Fries JF, Kraines RG, Roth SH. From experiment to experience: side effects of non-steroidal anti-inflammatory drugs. Am J Med 1983;74: 820-8.","journal-title":"Am J Med"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"517","DOI":"10.7326\/0003-4819-91-4-517","article-title":"Incidence ofgastric lesions in patients with rheumatic disease on chronic aspirin therapy","volume":"91","author":"Silvoso, G.R.; Ivey, K.J.; Butt, J.H.","year":"1979","unstructured":"Silvoso GR, Ivey KJ, Butt JH, et al. Incidence ofgastric lesions in patients with rheumatic disease on chronic aspirin therapy. Ann Intemn Med 1979;91: 517-20.","journal-title":"Ann Intemn Med"},{"key":"ref_6","first-page":"75","article-title":"Gastroscopic evaluation of anti-inflammatory agents","volume":"280","author":"Caruso 1, Porro GB","year":"1980","unstructured":"Caruso 1, Porro GB. Gastroscopic evaluation of anti-inflammatory agents. BrMedJ 1980;280:75-8.","journal-title":"BrMedJ"},{"key":"ref_7","first-page":"17","article-title":"A comparative endoscopic evaluation of the damaging effects of non-steroidal anti-inflammatory agents on the gastric and duodenal mucosa","volume":"75","author":"Lanza, F.L.; Royer, G.L.; Nelson, R.S.; Chen, T.T.; Seckman, C.E.; Rack, M.F.","year":"1981","unstructured":"Lanza FL, Royer GL, Nelson RS, Chen TT, Seckman CE, Rack MF. A comparative endoscopic evaluation of the damaging effects of non-steroidal anti-inflammatory agents on the gastric and duodenal mucosa. Am J7 Gastroenterol 1981;75:17-21.","journal-title":"Am J7 Gastroenterol"},{"key":"ref_8","first-page":"1246","article-title":"Symptoms in patients with peptic ulcer and hematemesis and\/or melena related to the use of non-steroid antiinflammatory drugs","volume":"20","author":"Mellem, H.; Stave, R.; Myren, J.","year":"1985","unstructured":"Mellem H, Stave R, Myren J, et al. Symptoms in patients with peptic ulcer and hematemesis and\/or melena related to the use of non-steroid antiinflammatory drugs. ScandJ(Gastroenterol 1985;20:1246-8.","journal-title":"ScandJ(Gastroenterol"},{"issue":"25","key":"ref_9","first-page":"50","article-title":"Contrasting presentation and findings between patients with rheumatic complaints taking non-steroidal antiinflammatory drugs and a general population referred for endoscopy","volume":"1986","author":"Collins, A.J.; Davies, J.; AStJ, Dixon","unstructured":"Collins AJ, Davies J, Dixon AStJ. Contrasting presentation and findings between patients with rheumatic complaints taking non-steroidal antiinflammatory drugs and a general population referred for endoscopy. BrJ Rheumatol 1986:25:50-3.","journal-title":"BrJ Rheumatol"},{"key":"ref_10","first-page":"1153","article-title":"Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic non-steroidal antiinflammatory drug use","volume":"82","author":"Larkai, E.N.; Smith, J.L.; Lidsky, M.D.; Graham, D.Y.","year":"1987","unstructured":"Larkai EN, Smith JL, Lidsky MD, Graham DY. Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic non-steroidal antiinflammatory drug use. AmJf Gastroenterol 1987;82:1153-8.","journal-title":"AmJf Gastroenterol"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1136\/gut.23.8.692","article-title":"Effects of 24 hours of aspirin, Bufferin, paracetamol and placebo on normal human gastroduodenal mucosa","volume":"23","author":"Hoftiezer, J.W.; O'Laughlin, J.C.; Ivey, K.J.","year":"1982","unstructured":"Hoftiezer JW, O'Laughlin JC, Ivey KJ. Effects of 24 hours of aspirin, Bufferin, paracetamol and placebo on normal human gastroduodenal mucosa. Gut 1982;23:692-7.","journal-title":"Gut"},{"key":"ref_12","first-page":"294","article-title":"Aspirin induced ultrastructural changes in human gastric mucosa","volume":"85","author":"Baskin, W.N.; Ivey, K.J.; Krause, W.; Jeffrey, E.; Gemmell, R.T.","year":"1976","unstructured":"Baskin WN, Ivey KJ, Krause W, Jeffrey E, Gemmell RT. Aspirin induced ultrastructural changes in human gastric mucosa. Ann Intern Med 1976;85: 294-303.","journal-title":"Ann Intern Med"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1056\/NEJM197405232902102","article-title":"Aspirin use in patients with major upper gastrointestinal bleeding and peptic ulcer disease","volume":"290","author":"Levy, M.","year":"1974","unstructured":"Levy M. Aspirin use in patients with major upper gastrointestinal bleeding and peptic ulcer disease. N EnglJ Med 1974;290:1158-62.","journal-title":"N EnglJ Med"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0140-6736(80)90452-3","article-title":"Reappraisal of the effects of aspirin on the stomach","volume":"ii:","author":"Rees, W.D.; Turnberg, L.A.","year":"1980","unstructured":"Rees WD, Turnberg LA. Reappraisal of the effects of aspirin on the stomach. Lancet 1980;ii:410-3.","journal-title":"Lancet"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1136\/gut.27.8.929","article-title":"Peptic ulcer and non-steroidal anti-inflammatory agents","volume":"27","author":"Duggan, J.M.; Dobson, A.J.; Johnson, H.; Fahey, P.","year":"1986","unstructured":"Duggan JM, Dobson AJ, Johnson H, Fahey P. Peptic ulcer and non-steroidal anti-inflammatory agents. Gut 1986;27:929-33.","journal-title":"Gut"},{"issue":"448-5","key":"ref_16","first-page":"1","article-title":"Peptic ulcer complications and the use of non-aspirin non-steroidal anti-inflammatorv drugs","volume":"120","author":"Langman, M.J.S.","year":"1986","unstructured":"Langman MJS. Peptic ulcer complications and the use of non-aspirin non-steroidal anti-inflammatorv drugs. Adverse Drug Reaction Bulletin 1986;120:448-5 1.","journal-title":"Adverse Drug Reaction Bulletin"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0140-6736(86)92927-2","article-title":"Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer","volume":"i:","author":"Somerville, K.; Faulkner, G.; Langman, M.","year":"1986","unstructured":"Somerville K, Faulkner G, Langman M. Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer. Lancet 1986;i:462-4.","journal-title":"Lancet"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1136\/gut.28.5.515","article-title":"Non-steroidal anti-inflammatory drugs-should every prescription carry a government health warning?","volume":"28","author":"Cockel, R.","year":"1987","unstructured":"Cockel R. Non-steroidal anti-inflammatory drugs-should every prescription carry a government health warning? Gut 1987;28:515-8.","journal-title":"Gut"},{"key":"ref_19","first-page":"489","article-title":"Rising frequency of ulcer perforation in elderly people in the United Kingdom","volume":"i:","author":"Walt, R.; Katschinski, B.; Logan, R.; Ashley, J.; Langman, M.","year":"1986","unstructured":"Walt R, Katschinski B, Logan R, Ashley J, Langman M. Rising frequency of ulcer perforation in elderly people in the United Kingdom. Lancet 1986;i: 489-92.","journal-title":"Lancet"},{"key":"ref_20","first-page":"13024","article-title":"years of hospital admissions for peptic ulcer in England and Wales","volume":"i:","author":"Coggon, D.; Lambert, P.; Langmnan, M.I.S.","year":"1981","unstructured":"Coggon D, Lambert P, Langmnan MIS. 20 years of hospital admissions for peptic ulcer in England and Wales. Lancet 1981;i: 13024.","journal-title":"Lancet"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1136\/gut.26.4.359","article-title":"Non-steroidal anti-inflammatory drugs and peptic ulcer perforation","volume":"26","author":"DStj, Collier; JA, Pain","year":"1985","unstructured":"Collier DStj, Pain JA. Non-steroidal anti-inflammatory drugs and peptic ulcer perforation. Gut 1985;26:359-63.","journal-title":"Gut"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1136\/gut.28.5.527","article-title":"Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration","volume":"28","author":"Armstrong, C.P.; Blower, A.L.","year":"1987","unstructured":"Armstrong CP, Blower AL. Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration. Gut 1987;28:527-32.","journal-title":"Gut"},{"key":"ref_23","first-page":"1227","article-title":"Fatal peptic ulcer complications and the use of non-steroidal anti-inflammatory drugs, aspirin, and corticosteroids","volume":"295","author":"Henry, D.A.; Johnston, A.; Dobson, A.; Duggan, J.","year":"1987","unstructured":"Henry DA, Johnston A, Dobson A, Duggan J. Fatal peptic ulcer complications and the use of non-steroidal anti-inflammatory drugs, aspirin, and corticosteroids. BrMedJ 1987;295: 1227-9.","journal-title":"BrMedJ"},{"key":"ref_24","first-page":"380","article-title":"Non-steroidal anti-inflammatory drugs and hospital admission for perforated peptic ulcer","volume":"ii:","author":"Jick, S.S.; Perera, D.R.; Walker, A.M.; Jick, H.","year":"1987","unstructured":"Jick SS, Perera DR, Walker AM, Jick H. Non-steroidal anti-inflammatory drugs and hospital admission for perforated peptic ulcer. Lancet 1987;ii:380.","journal-title":"Lancet"},{"key":"ref_25","first-page":"170","article-title":"Strategies for preventing aspirininduced gastric bleeding. Scand3'","volume":"21","author":"Hawkey, C.J.; Prichard, P.J.; Somerville, K.W.","year":"1986","unstructured":"Hawkey CJ, Prichard PJ, Somerville KW. Strategies for preventing aspirininduced gastric bleeding. Scand3' Gastroenterol[Suppl] 1986;21:170-3.","journal-title":"Gastroenterol[Suppl]"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/BF01296708","article-title":"Reduction of endoscopically assessed acute aspirin-induced gastric mucosal injury with cimetidine","volume":"32","author":"Kimmey, M.B.; Silverstein, F.E.; Saunders, D.R.; Chapman, R.C.","year":"1987","unstructured":"Kimmey MB, Silverstein FE, Saunders DR, Chapman RC. Reduction of endoscopically assessed acute aspirin-induced gastric mucosal injury with cimetidine. DigDis Sci 1987;32:851-6.","journal-title":"DigDis Sci"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1365-2036.1987.tb00638.x","article-title":"Cimnetidine decreases aspirin-induced gastric mucosal damage in humans","volume":"1","author":"Hogan, D.L.; Thomas, F.J.; Isenberg, J.I.","year":"1987","unstructured":"Hogan DL, Thomas FJ, Isenberg JI. Cimnetidine decreases aspirin-induced gastric mucosal damage in humans. Alimentary Pharmacology Therapeutics 1987;1:383-90.","journal-title":"Alimentary Pharmacology Therapeutics"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00004836-198606002-00009","article-title":"Reduction of aspirininduced gastroduodenal mucosal damage with ranitidine","volume":"8","author":"Berkowitz, J.M.; Adler, S.N.; Sharp, J.T.; Warner, C.W.","year":"1986","unstructured":"Berkowitz JM, Adler SN, Sharp JT, Warner CW. Reduction of aspirininduced gastroduodenal mucosal damage with ranitidine. J Clin Gastroenterol 1986;8:377-80.","journal-title":"J Clin Gastroenterol"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1001\/archinte.1987.00370120073014","article-title":"Ranitidine protects against gastroduodenal mucosal damage associated with chronic aspirin therapy","volume":"147","author":"Berkowitz, J.M.; Rogenes, P.R.; Sharp, J.T.; Warner, C.W.","year":"1987","unstructured":"Berkowitz JM, Rogenes PR, Sharp JT, Warner CW. Ranitidine protects against gastroduodenal mucosal damage associated with chronic aspirin therapy. Arch Intern Med 1987;147:2137-9.","journal-title":"Arch Intern Med"},{"key":"ref_30","article-title":"Statistical methods for rates and proportions","author":"Fleiss, J.L.","year":"1973","unstructured":"Fleiss JL. Statistical methods for rates and proportions. Chichester: Wiley, 1973."},{"key":"ref_31","first-page":"1313","article-title":"Calculating confidence intervals for relative risks (odds ratios) and standardised ratios and rates","volume":"296","author":"Morris, J.A.; Gardner, M.J.","year":"1988","unstructured":"Morris JA, Gardner MJ. Calculating confidence intervals for relative risks (odds ratios) and standardised ratios and rates. BrMedJ 1988;296:1313-6.","journal-title":"BrMedJ"},{"key":"ref_32","article-title":"Analysis ofbinary data","author":"Cox, DR","year":"1970","unstructured":"Cox DR. Analysis ofbinary data. London: Chapman Hail, 1970."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1001\/archinte.1987.00370100112018","article-title":"Cimetidine therapy in nonsteroidal anti-inflammatory drug gastropathy","volume":"147","author":"Roth, S.H.; Bennett, R.E.; Mitchell, C.S.; Hartman, R.J.","year":"1987","unstructured":"Roth SH, Bennett RE, Mitchell CS, Hartman RJ. Cimetidine therapy in nonsteroidal anti-inflammatory drug gastropathy. Arch Intern Med 1987;147: 1798-801.","journal-title":"Arch Intern Med"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1365-2036.1987.tb00663.x","article-title":"Why are non-steroidal anti-inflammatory drugs important in peptic ulceration?","volume":"1","author":"Porro, G.B.; Pace, F.; Caruso, I.","year":"1987","unstructured":"Porro GB, Pace F, Caruso I. Why are non-steroidal anti-inflammatory drugs important in peptic ulceration? Alimentary Pharmacology Therapeutics 1987;1(Suppl):540-7.","journal-title":"Alimentary Pharmacology Therapeutics"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/00004836-198708000-00008","article-title":"Duodenal mucosal injury with nonsteroidal anti-inflammatory drugs","volume":"9","author":"Eliakim, R.; Ophir, M.; Rachmilewitz, D.","year":"1987","unstructured":"Eliakim R, Ophir M, Rachmilewitz D. Duodenal mucosal injury with nonsteroidal anti-inflammatory drugs. J Clin Gastroenterol 1987;9:395-9.","journal-title":"J Clin Gastroenterol"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01393353","article-title":"Gastric adaptation occurs with aspirin administration in man","volume":"28","author":"Graham, D.Y.; Smith, J.L.; Dobbs, S.M.","year":"1983","unstructured":"Graham DY, Smith JL, Dobbs SM. Gastric adaptation occurs with aspirin administration in man. DigDis Sci 1983;28:1-6.","journal-title":"DigDis Sci"},{"key":"ref_37","first-page":"117","article-title":"Vicary FR. Peptic ulcers induced by piroxicam","volume":"290","author":"Fok, K.H.; George, P.J.M.","year":"1985","unstructured":"Fok KH, George PJM, Vicary FR. Peptic ulcers induced by piroxicam. Br MedJ3 1985;290:117."},{"key":"ref_38","first-page":"789","article-title":"Peptic ulcers induced by piroxicam","volume":"290","author":"Beermann, B.","year":"1985","unstructured":"Beermann B. Peptic ulcers induced by piroxicam. BrMedJ 1985;290:789.","journal-title":"BrMedJ"},{"key":"ref_39","first-page":"789","article-title":"Peptic ulcers induced by piroxicam","volume":"290","author":"Meyer, P.; Thiis, I.","year":"1985","unstructured":"Meyer P, Thiis I. Peptic ulcers induced by piroxicam. BrMedJ 1985;290:789.","journal-title":"BrMedJ"},{"key":"ref_40","first-page":"772","article-title":"Ulcerogenicity of piroxicam: an analysis of spontaneously reported data","volume":"294","author":"Armstrong, C.P.; Blower, A.L.","year":"1987","unstructured":"Armstrong CP, Blower AL. Ulcerogenicity of piroxicam: an analysis of spontaneously reported data. BrMedJ 1987;294:772.","journal-title":"BrMedJ"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1136\/bmj.290.6472.932-c","article-title":"Peptic ulcer and piroxicam","volume":"290","author":"Inman, W.H.W.; Rawson, N.S.B.","year":"1985","unstructured":"Inman WHW, Rawson NSB. Peptic ulcer and piroxicam. Br Med J 1985;290:932.","journal-title":"Br Med J"},{"key":"ref_42","first-page":"6","article-title":"The Norwegian multicenter study","volume":"SB):","author":"Husby, G.","year":"1986","unstructured":"Husby G. The Norwegian multicenter study. Am J Med 1986;81(Suppl SB): 6-10.","journal-title":"Am J Med"},{"key":"ref_43","first-page":"183","article-title":"Non-steroidal anti-inflammnatory drugs and peptic ulceration. J7 R Coll","volume":"21","author":"Clinch, D.; Banerjee, A.K.; Levy, D.W.; Ostick, G.; Faragher, E.B.","year":"1987","unstructured":"Clinch D, Banerjee AK, Levy DW, Ostick G, Faragher EB. Non-steroidal anti-inflammnatory drugs and peptic ulceration. J7 R Coll Physicians Lond 1987;21: 183-7.","journal-title":"Physicians Lond"}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bmj.297.6655.1017","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.297.6655.1017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T18:22:46Z","timestamp":1765477366000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.297.6655.1017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1988,10,22]]},"references-count":43,"journal-issue":{"issue":"6655","published-online":{"date-parts":[[1988,10,22]]},"published-print":{"date-parts":[[1988,10,22]]}},"alternative-id":["10.1136\/bmj.297.6655.1017"],"URL":"https:\/\/doi.org\/10.1136\/bmj.297.6655.1017","relation":{},"ISSN":["0959-8138","1468-5833"],"issn-type":[{"value":"0959-8138","type":"print"},{"value":"1468-5833","type":"electronic"}],"subject":[],"published":{"date-parts":[[1988,10,22]]}}}